Valuation: Zenotech Laboratories Limited

Market Cap 2.55B 26.48M 23.51M 22.01M 19.94M 37.62M 37.92M 264M 103M 1.3B 99.37M 97.23M 4.19B P/E 2025
56.5x
P/E 2026 -191x
Enterprise Value 2.25B 23.32M 20.71M 19.38M 17.57M 33.13M 33.4M 233M 90.47M 1.15B 87.52M 85.64M 3.69B EV / Sales 2025
7.42x
EV / Sales 2026 4.45x
Free-Float
15.47%
Yield 2025 *
-
Yield 2026 -
07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
04-29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
01-23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
31/10/25 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25/09/25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
28/07/25 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/03/25 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
28/01/25 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
23/10/24 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
23/10/24 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
26/07/24 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
17/05/24 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
1 day-0.78%
1 week-0.67%
Current month-0.07%
1 month-8.33%
3 months-8.95%
6 months-1.95%
Current year-9.50%
1 week 41
Extreme 41
44
1 month 41
Extreme 41
48
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
54.14
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 23/10/2024
Director of Finance/CFO - 06/02/2014
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member 59 08/07/2015
Chairman 68 -
Director/Board Member 53 01/02/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%-0.67%-20.89%-37.19% 26.7M
+1.26%-2.30%+37.82%+113.76% 1,019B
+0.73%-6.31%+35.06%+62.14% 610B
+0.35%+0.15%+14.01%+80.87% 470B
+1.72%-4.54%+59.14%+37.01% 344B
+0.26%-1.58%+21.97%+41.79% 336B
+0.60%-3.48%+11.37%+34.33% 266B
+1.65%-4.27%-5.47%+9.69% 241B
-0.09%-3.71%+35.15%+51.88% 218B
-0.28%-5.24%+27.99%+93.08% 179B
Average +0.29%-3.25%+21.61%+48.74% 368.29B
Weighted average by Cap. +0.32%-3.51%+29.49%+70.06%

Financials

2025 2026
Net sales 391M 4.06M 3.6M 3.37M 3.06M 5.77M 5.81M 40.51M 15.74M 200M 15.23M 14.9M 642M 402M 4.17M 3.7M 3.46M 3.14M 5.92M 5.97M 41.61M 16.17M 205M 15.65M 15.31M 659M
Net income 56.13M 583K 517K 484K 439K 828K 834K 5.81M 2.26M 28.64M 2.19M 2.14M 92.14M -10.72M -111K -98.8K -92.48K -83.82K -158K -159K -1.11M -432K -5.47M -418K -409K -17.6M
Net Debt -267M -2.77M -2.46M -2.3M -2.09M -3.94M -3.97M -27.67M -10.75M -136M -10.4M -10.18M -438M -304M -3.16M -2.8M -2.62M -2.38M -4.49M -4.52M -31.52M -12.25M -155M -11.85M -11.6M -499M
Projected Income Statement - Annual - Zenotech Laboratories Limited
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
264
Date Price Change Volume
06/10/26 ₹41.80 -0.78% 22,279
05/10/26 ₹42.13 +0.33% 8,235
01/10/26 ₹41.99 +0.38% 8,071
30/09/26 ₹41.83 -1.60% 10,469
29/09/26 ₹42.51 +1.02% 4,709
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock